Patients with MCI and mild Alzheimer’s disease exhibited elevated serum CCL2 and cerebrospinal fluid levels, which likely represents an early event in the pathogenesis of Alzheimer’s disease, far preceding the clinical onset of the disease [51]. This evidence concerns the gene CCL2 and early-onset autosomal dominant Alzheimer disease.